Courses target Chinese drug makers

Industry group ISPE is partnering with the China Centre for Pharmaceutical International Exchange (CCPIE) to bring training courses tailored to the needs of the Chinese pharmaceutical industry. Industry leader Gordon Farquharson will be presenting courses on sterile drug manufacturing facilities and pharmaceutical water systems.

The Sterile Drug Manufacturing Facilities: Applying ISPE Baseline Guide, FDA, EU/PICS and WHO Principles to Design and Operation course will review ISPE's sterile manufacturing facilities baseline guide, the FDA's 2004 Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing--Current Good Manufacturing Practice, and the March 2009 implementation of Annex 1 of the EU GMP, according to an announcement. The course is intended to help participants understand the key requirements and GMPs for sterile product manufacturing facilities.

In the second course, Pharmaceutical Water Systems: Regulation, Purification, Distribution and Validation, participants will review the principles of design and operation of water systems used in pharmaceutical manufacturing, including the regulatory requirements, concepts, and principles for systems used to generate, store and distribute both compendial and non-compendial waters.

- read the course descriptions

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.